Literature DB >> 17314345

Treating COPD--the TORCH trial, P values, and the Dodo.

Klaus F Rabe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17314345     DOI: 10.1056/NEJMe068307

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  19 in total

1.  The ongoing tyranny of statistical significance testing in biomedical research.

Authors:  Andreas Stang; Charles Poole; Oliver Kuss
Journal:  Eur J Epidemiol       Date:  2010-03-26       Impact factor: 8.082

2.  [Impact of COPD therapy on patient survival: the TORCH Study (TOwards a Revolution in COPD Health)].

Authors:  S Nitschmann; G Schultze-Werninghaus
Journal:  Internist (Berl)       Date:  2007-12       Impact factor: 0.743

3.  The efficacy and safety of cilomilast in COPD. Forward.

Authors:  Alvar Agusti
Journal:  Drugs       Date:  2008       Impact factor: 9.546

4.  Re-evaluation of combination therapy in chronic obstructive pulmonary disease (COPD).

Authors:  Carlos A Vaz Fragoso; Thomas M Gill; Linda S Leo-Summers; Peter H Van Ness
Journal:  Respir Med       Date:  2019-03-29       Impact factor: 3.415

Review 5.  Salmeterol/fluticasone propionate: a review of its use in the treatment of chronic obstructive pulmonary disease.

Authors:  Gillian M Keating; Paul L McCormack
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 6.  Focusing on outcomes: making the most of COPD interventions.

Authors:  Noreen M Clark; Julia A Dodge; Martyn R Partridge; Fernando J Martinez
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-04-15

Review 7.  Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing.

Authors:  Preeti Gupta; M Sinead O'Mahony
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

8.  Targeting lung inflammation: novel therapies for the treatment of COPD.

Authors:  Hongwei Yao; Willem I de Boer; Irfan Rahman
Journal:  Curr Respir Med Rev       Date:  2008

Review 9.  Long-acting beta2-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safety.

Authors:  Andrea Rossi; Sonia Khirani; Mario Cazzola
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

Review 10.  Pathological networking: a new approach to understanding COPD.

Authors:  Ian Sabroe; Lisa C Parker; Peter M A Calverley; Steven K Dower; Moira K B Whyte
Journal:  Thorax       Date:  2007-08       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.